Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients
Clinical trial NCT02431351 · WITHDRAWN
Trial details
- NCT number
- NCT02431351
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.